omega-n-methylarginine has been researched along with melatonin in 15 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (melatonin) | Trials (melatonin) | Recent Studies (post-2010) (melatonin) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 23,268 | 1,451 | 9,627 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | melatonin (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 3 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 3.3323 | |
| Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.0004 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Melatonin receptor type 1A | Homo sapiens (human) | 0.0025 | |
| Melatonin receptor type 1B | Homo sapiens (human) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 12 (80.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Hayashi, K; Okatani, Y; Sagara, Y; Wakatsuki, A; Watanabe, K | 1 |
| Acuña-Castroviejo, D; Crespo, E; Escames, G; Guerrero, JM; Macías, M; Martín, M; Pozo, D; Vives, F | 1 |
| Fukaya, T; Ikenoue, N; Okatani, Y; Wakatsuki, A; Watanabe, K | 1 |
| Okatani, Y; Reiter, RJ; Wakatsuki, A | 1 |
| Fukaya, T; Okatani, Y; Wakatsuki, A; Watanabe, K | 1 |
| Fukaya, T; Okatani, Y; Taniguchi, K; Wakatsuki, A; Watanabe, K | 2 |
| Delagrange, P; O'Rourke, ST; Scalbert, E; Vanhoutte, PM; Yang, Q | 1 |
| Acuña-Castroviejo, D; Escames, G; Khaldy, H; León, J; Macías, M | 1 |
| Karanth, S; Mastronardi, CA; McCann, SM; Yu, WH | 1 |
| Bertuglia, S; Reiter, RJ | 1 |
| Bzhozovs'kyĭ, T; Hzhehots'kyĭ, MR; Konturek, SIa; Slivovs'kyĭ, Z; Zaiachkivs'ka, OS | 1 |
| Fung, ML; Hung, MW; Li, MF; Tjong, YW | 1 |
| Okada, T; Takahashi, Y | 1 |
15 other study(ies) available for omega-n-methylarginine and melatonin
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Melatonin inhibits vasospastic action of hydrogen peroxide in human umbilical artery.
Topics: Antioxidants; Female; Free Radical Scavengers; Humans; Hydrogen Peroxide; In Vitro Techniques; Infant, Newborn; Melatonin; Nitric Oxide; omega-N-Methylarginine; Pre-Eclampsia; Pregnancy; Umbilical Arteries; Vasoconstriction | 1997 |
Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats.
Topics: Animals; Drug Administration Schedule; Endotoxemia; Gene Expression Regulation, Enzymologic; Kidney; Lipid Peroxidation; Lipopolysaccharides; Liver; Lung; Male; Melatonin; Multiple Organ Failure; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Transcription, Genetic | 1999 |
Melatonin inhibits vasospastic action of oxidized low-density lipoprotein in human umbilical arteries.
Topics: Antioxidants; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; In Vitro Techniques; Isometric Contraction; Lipoproteins, LDL; Mannitol; Melatonin; omega-N-Methylarginine; Placenta; Potassium Chloride; Umbilical Arteries; Vasoconstriction | 2000 |
Protective effect of melatonin against homocysteine-induced vasoconstriction of human umbilical artery.
Topics: Analysis of Variance; Antioxidants; Calcimycin; Cell-Free System; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Homocysteine; Humans; Ionophores; Iron; Melatonin; Muscle, Smooth; Nitric Oxide; omega-N-Methylarginine; Oxidative Stress; Oxygen; Time Factors; Umbilical Arteries; Vasoconstriction | 2000 |
Attenuation by melatonin of human umbilical arterial vasoconstriction induced by lysophosphatidylcholine.
Topics: Adult; Antioxidants; Catalase; Dose-Response Relationship, Drug; Electrophysiology; Endothelium, Vascular; Enzyme Inhibitors; Female; Free Radical Scavengers; Humans; Lysophosphatidylcholines; Mannitol; Melatonin; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Potassium Chloride; Serotonin; Umbilical Arteries; Vasoconstriction; Vasodilation | 2000 |
Melatonin suppresses lysophosphatidylcholine enhancement of serotonin-induced vasoconstriction in the human umbilical artery.
Topics: Adult; Dose-Response Relationship, Drug; Drug Synergism; Female; Free Radical Scavengers; Humans; Indomethacin; Lysophosphatidylcholines; Mannitol; Melatonin; Muscle, Smooth, Vascular; omega-N-Methylarginine; Pregnancy; Serotonin; Umbilical Arteries; Vasoconstriction | 2000 |
Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Vessels; Drug Synergism; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Melatonin; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Serotonin; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Weak vasoconstrictor activity of melatonin in human umbilical artery: relation to nitric oxide-scavenging action.
Topics: Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Free Radical Scavengers; Humans; In Vitro Techniques; Melatonin; Nitric Oxide Synthase; omega-N-Methylarginine; Umbilical Arteries; Vasoconstriction | 2001 |
Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats.
Topics: Aging; Animals; Electron Transport Complex I; Electron Transport Complex IV; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; Lipopolysaccharides; Melatonin; Mitochondria; NADH, NADPH Oxidoreductases; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Rats | 2003 |
Inhibition of melatonin-induced ascorbic acid and LHRH release by a nitric oxide synthase and cyclic GMP inhibitor.
Topics: Aminoquinolines; Animals; Ascorbic Acid; Cyclic GMP; Enzyme Inhibitors; Gonadotropin-Releasing Hormone; Guanylate Cyclase; Male; Melatonin; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley | 2004 |
Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters.
Topics: Angiotensin II; Animals; Antioxidants; Arrhythmias, Cardiac; Arterioles; Capillary Permeability; Cardiomyopathy, Dilated; Cell Adhesion; Cricetinae; Endothelium, Vascular; Leukocytes; Lipid Peroxidation; Male; Melatonin; Mesocricetus; Microcirculation; Nitrates; Nitrites; Norepinephrine; omega-N-Methylarginine; Reperfusion Injury | 2007 |
[The cytokine profile during experimental esophagitis and modification of cytoprotective mechanisms].
Topics: Animals; Cyclooxygenase Inhibitors; Cytokines; Cytoprotection; Disease Models, Animal; Esophagitis; Male; Melatonin; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pepsin A; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar | 2006 |
Melatonin ameliorates hippocampal nitric oxide production and large conductance calcium-activated potassium channel activity in chronic intermittent hypoxia.
Topics: Animals; Hippocampus; Hypoxia; Large-Conductance Calcium-Activated Potassium Channels; Male; Melatonin; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley | 2008 |
Involvement of the nitric oxide cascade in melatonin-induced inhibition of long-term potentiation at hippocampal CA1 synapses.
Topics: Animals; CA1 Region, Hippocampal; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Hydrazines; Long-Term Potentiation; Male; Melatonin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; omega-N-Methylarginine; Pyramidal Cells; Rats; Rats, Wistar; Synapses; Synaptic Transmission; Tetanus Toxin | 2011 |